Bryce Baker

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease”.

Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease

JAMA Neurology(2024)10.1001/jamaneurol.2024.0991

N/A

1.0DataRank · unranked

29 citations

Haiyan Liu, Guoqiao Wang, Xinyu Shi, Tobias Bittner, Marzia A. Scelsi +94 more

γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

The Lancet Neurology(2024)10.1016/s1474-4422(24)00236-9

N/A

0DataRank · unranked

33 citations

Lei Liu, Aaron P. Schultz, Colleen Fitzpatrick, Raina Levin, Jean‐Pierre Bellier +94 more

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Nature Communications(2024)10.1038/s41467-024-52937-8

N/A

0DataRank · unranked

28 citations

Lisa M. Häsler, Marius Lambert, Stephan A. Kaeser, Susanne Gräber‐Sultan, Ulrike Obermüller +88 more

Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease

Acta Neuropathologica(2025)10.1007/s00401-025-02890-7

N/A

0DataRank · unranked

5 citations

Erin Franklin, Yan Li, Nelly Joseph‐Mathurin, Aime Burns, Diana A. Hobbs +93 more